BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Castillo-Castro C, Martagón-Rosado AJ, Ortiz-Lopez R, Garrido-Treviño LF, Villegas-Albo M, Bosques-Padilla FJ. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World J Hepatol 2021; 13(11): 1494-1511 [PMID: 34904026 DOI: 10.4254/wjh.v13.i11.1494]
URL: https://www.wjgnet.com/2307-8960/full/v13/i11/1494.htm
Number Citing Articles
1
Xiaofeng Liu, Shuzhen Yu, Yao Zhang, Wei Zhang, Hao Zhong, Xiaoqin Lu, Rongfa Guan. A review on the protective effect of active components in Antrodia camphorata against alcoholic liver injuryJournal of Ethnopharmacology 2023; 300: 115740 doi: 10.1016/j.jep.2022.115740
2
Kaitlyn G. Jackson, Grayson W. Way, Huiping Zhou. Bile acids and sphingolipids in non-alcoholic fatty liver diseaseChinese Medical Journal 2022; 135(10): 1163 doi: 10.1097/CM9.0000000000002156
3
Abena S Agyeman, Abbas Bandukwala, Khaled Bouri, Jessica Hawes, Daniel M Krainak, Samir Lababidi, William B Mattes, Elena V Mishina, Phillip Turfle, Sue-Jane Wang, Theresa Thekkudan. US FDA public meeting: identification of concepts and terminology for multicomponent biomarkersBiomarkers in Medicine 2023; 17(11): 523 doi: 10.2217/bmm-2023-0351
4
Nuria Perez-Diaz-del-Campo, Diego Martínez-Urbistondo, Elisabetta Bugianesi, J. Alfredo Martínez. Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicineCurrent Opinion in Clinical Nutrition & Metabolic Care 2022; 25(5): 285 doi: 10.1097/MCO.0000000000000849
5
Guido Bocci, Paola Orlandi, Maria Laura Manca, Chiara Rossi, Antonio Salvati, Maurizia Rossana Brunetto, Anna Solini. Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver DiseasesJournal of Clinical Medicine 2022; 11(20): 5985 doi: 10.3390/jcm11205985